ArticleFrontiers in pharmacology2024

Shenling Baizhu San ameliorates non-alcoholic fatty liver disease in mice by modulating gut microbiota and metabolites.

Dongliang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.